Sao Paulo expects regulator approval for Sinovac vaccine by January

SAO PAULO, Nov 23 (Reuters) - Sao Paulo Health Secretary Jean Gorinchteyn said on Monday he expects Brazil's regulator to approve the COVID-19 vaccine developed by China's Sinovac by January.

Gorinchteyn said the Butantan biomedical research institute, that is running the late-stage trials of the Sinovac vaccine in Brazil, has now reached the minimum number of infected cases to register the vaccine. (Reporting by Eduardo Simoes, writing by Stephen Eisenhammer; Editing by Chizu Nomiyama)